V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250001973 | 250008217 | 1.49 | 85.3 | null | null | 2021-07-02 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100997981 |
| 250001989 | 250008218 | 1.84 | null | Palliative (P) | 2019-08-21 | 2019-08-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100066854 |
| 250001991 | 250008219 | 1.64 | 54.3 | null | null | 2020-03-29 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | NIVOLUMAB | 100150107 |
| 250001992 | 250008220 | 1.66 | 82 | null | 2021-01-12 | 2021-01-19 | CISPLATIN + GEMCITABINE | 02 | null | NIVOLUMAB | 100629719 |
| 250002022 | 250008224 | 1.73 | 51.2 | null | null | 2016-05-14 | null | null | null | CARBOPLATIN + GEMCITABINE | 101796812 |
| 250002027 | 250008225 | 1.74 | null | null | null | 2018-10-28 | null | null | null | NIVOLUMAB | 101518277 |
| 250002028 | 250008226 | 1.74 | 62.4 | null | 2017-02-24 | 2017-03-06 | null | 02 | null | NIVOLUMAB | 101207935 |
| 250002059 | 250008232 | 1.87 | 113.6 | null | null | 2020-02-19 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100232944 |
| 250002060 | 250008233 | 1.61 | null | null | 2019-03-04 | 2019-03-14 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101603681 |
| 250002069 | 250008235 | 1.62 | 115.9 | null | null | 2019-09-12 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100019413 |
| 250002078 | 250008238 | 1.76 | 64.6 | Palliative (P) | 2021-01-24 | 2021-02-07 | null | 02 | N | CISPLATIN + GEMCITABINE | 100686510 |
| 250002081 | 250008239 | 1.67 | 85.4 | null | null | 2019-05-02 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101847557 |
| 250002082 | 250008240 | 1.62 | 62.4 | Palliative (P) | 2020-10-04 | 2020-10-08 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101377845 |
| 250002083 | 250008241 | 1.45 | 98.8 | Palliative (P) | 2019-10-17 | 2019-11-06 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101586927 |
| 250002107 | 250008248 | 1.55 | 0 | Palliative (P) | 2019-06-22 | 2019-06-24 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 100626278 |
| 250002126 | 250008252 | 1.75 | 65.4 | null | null | 2017-05-13 | null | null | null | CARBOPLATIN + GEMCITABINE | 100989388 |
| 250002129 | 250008253 | 1.73 | 65.35 | null | 2020-07-12 | 2020-07-13 | Atezolizumab | 01 | null | CETUXIMAB + IRINOTECAN + MDG | 100892019 |
| 250002131 | 250008255 | null | null | null | null | 2020-05-26 | null | null | null | COMPARE TRIAL | 100919250 |
| 250002153 | 250008261 | null | null | Palliative (P) | null | 2021-03-08 | null | null | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100292841 |
| 250002168 | 250008264 | 0 | 12 | null | null | 2020-09-11 | PACLITAXEL | null | N | CISPLATIN | 100434701 |
| 250002186 | 250008268 | null | null | Palliative (P) | null | 2019-12-04 | null | null | N | NB HRNBL-1 COJEC IND COURSE C | 100759721 |
| 250002189 | 250008270 | null | null | Neo-adjuvant (N) | 2017-05-04 | 2017-07-12 | Cisplatin | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 100959745 |
| 250002215 | 250008272 | null | null | null | null | 2019-01-28 | NB HRNBL-1 Isotretinoin | null | N | CETUXIMAB | 101174841 |
| 250002223 | 250008273 | 1.66 | 63.1 | Palliative (P) | 2018-06-23 | 2018-06-25 | Enzalutamide | 02 | Y | EURO-EWING | 101307704 |
| 250002237 | 250008277 | null | null | null | null | 2019-11-27 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100773104 |
| 250002243 | 250008281 | null | null | null | 2020-04-03 | 2020-04-03 | null | N | null | GEMCITABINE | 101222663 |
| 250002245 | 250008282 | null | null | Palliative (P) | 2018-03-16 | 2018-03-18 | STS Non-Rhabdo EpSSG 2005 IE | N | N | FLUOROURACIL + MITOMYCIN + RT | 100936287 |
| 250002247 | 250008283 | 1.21 | 70 | Curative (C) | 2019-12-06 | 2020-01-16 | VDC | 01 | null | PAZOPANIB | 100741886 |
| 250002255 | 250008287 | 1.79 | 88.4 | Palliative (P) | 2019-07-17 | 2019-07-29 | Trial Unspecified | 02 | N | DOCETAXEL + GEMCITABINE | 100518658 |
| 250002261 | 250008288 | 1.67 | 78.2 | null | null | 2016-06-14 | null | 02 | null | CNS LOW GRADE GLIOMA VINBLASTINE | 100634456 |
| 250002263 | 250008289 | 1.63 | 105.9 | Palliative (P) | 2017-10-28 | 2018-02-05 | CARBOPLATIN + ETOPOSIDE | 02 | null | CETUXIMAB | 100975579 |
| 250002269 | 250008291 | null | null | null | null | 2021-10-21 | TEMOZOLOMIDE | null | N | PAZOPANIB | 101137375 |
| 250002272 | 250008293 | 1.85 | 65.4 | null | null | 2019-08-28 | null | 02 | N | CABOZANTINIB | 100196390 |
| 250002298 | 250008299 | null | null | null | 2017-12-25 | 2017-12-25 | ICON9 TRIAL | N | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 100590078 |
| 250002303 | 250008300 | null | null | Neo-adjuvant (N) | 2019-10-19 | 2019-11-09 | null | 02 | null | ENZALUTAMIDE | 100982714 |
| 250002305 | 250008301 | 1.94 | 67.3 | Palliative (P) | 2017-03-19 | 2017-04-06 | BEP 5 Day | 01 | N | PACLITAXEL | 101639644 |
| 250002307 | 250008303 | null | null | null | 2019-12-05 | 2019-12-13 | null | 02 | null | TRIAL UNSPECIFIED | 101329965 |
| 250002313 | 250008306 | 1.76 | 78.3 | Palliative (P) | 2019-07-06 | 2019-07-06 | DOXORUBICIN | 02 | N | CARBOPLATIN + PEMETREXED | 101535452 |
| 250002314 | 250008307 | 1.81 | 71 | Palliative (P) | 2017-10-22 | 2017-10-22 | Atezolizumab | 02 | N | CETUXIMAB | 101026921 |
| 250002320 | 250008309 | 1.69 | 66.2 | Palliative (P) | 2019-09-24 | 2019-09-29 | Atezolizumab | 02 | N | ATEZOLIZUMAB | 101137656 |
| 250002328 | 250008310 | 1.71 | 99.4 | Palliative (P) | null | 2016-11-26 | Cisplatin | 02 | null | CARBOPLATIN + PACLITAXEL | 101387472 |
| 250002333 | 250008312 | 1.94 | 100.7 | Palliative (P) | 2021-05-20 | 2021-05-20 | IPM | 02 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101519263 |
| 250002334 | 250008313 | null | null | null | 2019-11-11 | 2019-11-12 | ABVD | 02 | N | AVELUMAB + AXITINIB | 101637139 |
| 250002342 | 250008315 | 0 | 69.7 | null | 2021-07-21 | 2021-07-21 | NB HRNBL-1 Isotretinoin | 02 | N | CISPLATIN | 100644136 |
| 250002349 | 250008317 | 1.7 | 79.4 | Palliative (P) | 2018-06-27 | 2018-07-16 | Bevacizumab 7.5mg/kg | N | N | CABOZANTINIB | 101207029 |
| 250002350 | 250008318 | 1.7 | null | Curative (C) | 2019-10-21 | 2019-10-22 | null | 02 | null | DOCETAXEL | 101415326 |
| 250002352 | 250008319 | 1.58 | 100 | Palliative (P) | null | 2020-03-02 | null | null | null | PAZOPANIB | 100092336 |
| 250002363 | 250008321 | null | null | null | null | 2021-04-21 | Carboplatin + Pemetrexed | null | null | AXITINIB | 100936005 |
| 250002373 | 250008322 | null | null | null | null | 2019-04-17 | Sunitinib | null | null | CARBOPLATIN + PACLITAXEL | 100387475 |
| 250002383 | 250008325 | 1.83 | 62.2 | Palliative (P) | 2020-03-29 | 2020-04-05 | CABOZANTINIB | 02 | null | CETUXIMAB | 101814106 |